Dr. Naveen Pemmaraju is an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. He completed undergraduate studies with a Bachelor of Science cum laude in Cell and Molecular Biology at Tulane University. He received his medical degree at the University of Arkansas for Medical Sciences, completed Internal Medicine training at the Osler Medical Program of Johns Hopkins (Barker Firm), and completed a fellowship in Hematology/Oncology at MD Anderson Cancer Center.
Dr. Pemmaraju is board-certified in Internal Medicine, Hematology and Oncology. Pemmaraju has extensive experience with clinical trial design, enrollment of patients, and serving as the PI or co-PI of several enrolling and upcoming clinical trials at his institution. He serves as the co-course director for the Leukemia rotation and is a member of the Fellowship Educational Steering Committee at MD Anderson. He has been a consultant or received research support from Incyte, Novartis, LFB, Stemline, Cellectis and Roche Diagnostics.